Hundreds of urothelial cancer patients to receive new treatment
NICE recommends avelumab as treatment for adults with locally advanced or metastatic urothelial cancer
Read More
Author: John Pinching
Kynos Therapeutics targets inflammation-driven illness
Spin-off company will focus on developing therapies in areas of inflammation and immunometabolism
Read More
Alpha brain waves can predict post-surgery pain
A technique developed by the University of Birmingham demonstrates link between patients’ alpha brain waves and responses to pain
Read More
Gilead Sciences opens new drug development hub in Dublin
New Dublin development office will be responsible for paediatric clinical trials for seven products across 18 countries
Read More
Novartis presents positive new data on relapsing MS treatment
Data has shown that treatment with Kesimpta is associated with fewer relapses and reduced risk of worsening disability
Read More- Pierre Fabre Laboratories secures CHMP backing for first‑line BRAFTOVI regimen
- Resolution Therapeutics hails positive 4‑year MATCH data in liver cirrhosis
- KOALA trial opens to enrol patients for first‑in‑human KMCAR T‑cell therapy
- Pepaxti study supports use in wider myeloma population
- UCB reports positive outcomes for bimekizumab in psoriatic arthritis
